Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms
At the end of 2019, the entire world has witnessed the birth of a new member of coronavirus family in Wuhan, China. Ever since, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has swiftly invaded every corner on the planet. By the end of April 2020, almost 3.5 million cases have bee...
- Autores:
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12104
- Acceso en línea:
- https://doi.org/10.1016/j.mehy.2020.110033
http://hdl.handle.net/20.500.12010/12104
- Palabra clave:
- COVID-19
SARS-CoV-2
Cytokines
Cytochrome P450
Metabolism
Pharmacokinetics
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Acceso restringido